Template:Norethisterone metabolism mini
Jump to navigation
Jump to search
Template documentation
To transclude this template, use:
{{Norethisterone metabolism | caption = | align = }}
- Optional parameters
- The parameter
| caption =
may be used to add an image caption. - The parameter
| align =
may be set as left, right, or center. Center is the default image alignment when this parameter is not set as one of the two alternatives (i.e., left or right).
The image's alternative text (i.e., the |alt=
parameter) is "Norethisterone metabolism". The alt parameter can't be changed when transcluding this template.
- Reflist for template header
References
- ↑ J. H. H. Thijssen (September 1972). "Metabolism of Orally Active Synthetic Progestational Compounds". In M. Tausk (ed.). Pharmacology of the Endocrine System and Related Drugs: Progesterone, Progestational Drugs and Antifertility Agents. Vol. II. Pergamon Press. pp. 217–273. ISBN 978-0080168128. OCLC 278011135.
- ↑ Okada, Hiroji (2010). "Receptors and Mechanism Action of Synthetic Progestogens". Asia-Oceania Journal of Obstetrics and Gynaecology. 7 (1): 15–27. doi:10.1111/j.1447-0756.1981.tb00511.x. ISSN 0389-2328.
- ↑ Briggs, M. H. (1980). "Comparative Pharmacodynamics and Pharmacokinetics of Contraceptive Steroids in Animals and Man: A Selective Review". Clinical Pharmacology & Therapeutics. pp. 493–518. doi:10.1007/978-1-349-05952-2_57. ISBN 978-1-349-05954-6.
- ↑ Thomas, John A.; Keenan, Edward J. (1986). "Progestins and Oral Contraceptives". Principles of Endocrine Pharmacology. pp. 167–196. doi:10.1007/978-1-4684-5036-1_8. ISBN 978-1-4684-5036-1.
- ↑ Orme ML, Back DJ, Breckenridge AM (1983). "Clinical pharmacokinetics of oral contraceptive steroids". Clin Pharmacokinet. 8 (2): 95–136. doi:10.2165/00003088-198308020-00001. PMID 6342899. S2CID 43298472.
- ↑ Fotherby K (1974). "Metabolism of synthetic steroids by animals and man". Acta Endocrinol Suppl (Copenh). 185: 119–47. doi:10.1530/acta.0.075s119. PMID 4206183.
- ↑ Kuhl H (September 1990). "Pharmacokinetics of oestrogens and progestogens". Maturitas. 12 (3): 171–97. doi:10.1016/0378-5122(90)90003-o. PMID 2170822.
- ↑ Kuhl H (2011). "Pharmacology of Progestogens" (PDF). J Reproduktionsmed Endokrinol. 8 (1): 157–177.
- ↑ Kuhl, H. (2005). "Pharmacology of estrogens and progestogens: Influence of different routes of administration". Climacteric : The Journal of the International Menopause Society. 8 Suppl 1: 3–63. doi:10.1080/13697130500148875. PMID 16112947. S2CID 24616324.
- ↑ Kuhl H, Wiegratz I (August 2007). "Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications?". Climacteric. 10 (4): 344–53. doi:10.1080/13697130701380434. PMID 17653961. S2CID 20759583.
- ↑ Stanczyk, Frank Z.; Roy, Subir (1990). "Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids". Contraception. 42 (1): 67–96. doi:10.1016/0010-7824(90)90093-B. ISSN 0010-7824. PMID 2143719.